Oncology

Pfizer’s Lung‑Cancer Experiment Stumbles: No Survival Edge Found

AbbVie’s $11 Billion Bet on Oncology: Acquiring Apogee Therapeutics

AbbVie’s $11 Billion Bet on Cancer Innovation

When AI Talks Cancer: Empowering Patients, Challenging Doctors

Johnson & Johnson's Bold Bet: Steering Clear of GLP-1 Hype to Double Down on Oncology

India’s First Dedicated Myeloma‑Lymphoma Centre Opens in Gurugram

ELVN Shares Poised for Best Weekly Gain Since March Amid FDA Development Pathway News

The Unsettling Truth: Why Younger Generations Can't Afford to Ignore Blood in Stool

A New Era in Cancer Treatment: How Robotic Precision is Transforming Care at VGH

A Beacon of Hope: New Pancreatic Cancer Drug Doubles Survival

Rajeev Khandelwal’s Leafy Hope: Growing Soursop for His Mother’s Cancer Battle

Hope in Numbers: Singapore’s Young Cancer Support Group Empowers Patients

Reliance Hospitals Announces India's First Breakthrough Cancer Treatment

AkeSO’s Lung‑Cancer Drug Shows a Survival Edge Over the Current Standard

Breakthrough Oral Pill Offers Fresh Hope for Pancreatic Cancer Patients

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

The Power of a Second Look: Why Another Medical Opinion Can Be a Lifesaver in Cancer Care

United Front: How Dana-Farber and Firefighters Are Tackling Cancer Head-On

How Gene‑Therapy Is Turning the Tide Against Tumors

The Molecular Revolution: How 'Grappling' Could Transform Cancer Drug Effectiveness

Natera's Q1: A Story of Robust Revenue Growth and Lingering Losses

Merck's Bold Bet: A Deep Dive into the Pipeline Powering Post-Keytruda Growth

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

A Beacon of Hope: Personalized mRNA Vaccine Targets Pancreatic Cancer Recurrence

A Beacon of Hope: Personalized mRNA Cancer Vaccine Shows Promise Against Pancreatic Cancer

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

A Glimmer of Hope: New Experimental Treatment Offers Breakthrough for Pancreatic Cancer Patients

A New Era of Hope: Revolutionizing Pancreatic Cancer Treatment

Telix and Regeneron Unite: A Groundbreaking Alliance for Radiopharmaceutical Innovation

BioNTech Navigates Shifting Tides: Q1 2026 Showcases Pipeline Progress Amidst Revenue Recalibration

Avacta Marks Pivotal Moment: First Patient Dosed in AVA6103 Cancer Trial

A New Chapter Unfolds: Cue Biopharma Announces Leadership Transition Amidst Clinical Advancements

Lantern Pharma Gears Up to Unveil Its Transformative 2025 Financial Story and Operational Triumphs

Navin Fluorine's Bold Leap: A Rs 1,400 Crore Bet on the Future of Fluorochemicals

A New Dawn in Prostate Cancer Treatment: Turbocharging the Immune System

Molecular Partners Charts a Course for Innovation: Major Cancer Research Unveiling at AACR 2026

Unlocking New Hope: BlossomHill Therapeutics Takes Aim at Toughest KRAS Cancers

A Glimmer of Hope: Beyond Cancer's Early Clinical Results Spark Optimism

A New Dawn for Breast Cancer Survivors: Quebec Pioneers Personalized Follow-Up